Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas

Título:

Autor:

Giselle Fernandes Taboada

Ano:

2015

DOI:

10.1016/j.canlet.2015.01.037

Revista:

Cancer Letters (Print)

ISSN:

03043835

Tags:

Somatotropinomas

acromegalia

sst5TMD4

Agressividade Tumoral

Home:

[doi:10.1016/j.canlet.2015.01.037]

Idioma:

Inglês

Buscar essa publicação no Google Acadêmico

Publicações com a mesma autoria

Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas.

Utility of [(18)F] fluoro-2-deoxy-D: -glucose positron emission tomography in the localization of ectopic ACTH-secreting tumors.

Impact of gsp Oncogene on the mRNA Content for Somatostatin and Dopamine Receptors in Human Somatotropinomas

Acromegaly secondary to growth hormone-releasing hormone secreted by an incidentally discovered pheochromocytoma.

Prolactinomas may have unusual presentations resulting from massive extrasellar tumor extension

Prevalence of gsp oncogene in somatotropinomas and clinically non-functioning pituitary adenomas: our experience.

Somatostatin receptors subtypes 2 and 5, dopamine receptor type 2 expression and gsp status as predictors of octreotide LAR responsiveness in acromegaly.

Prevalence of vitamin B12 deficiency in type 2 diabetic patients using metformin: a cross-sectional study

Subgaleal recurrence of craniopharyngioma of rapid growing pattern

Fatores de risco relacionados à retinopatia em pacientes com diabetes mellitus tipo 2